Free Trial

Lexaria Bioscience (LEXX) Insider Trading & Ownership

Lexaria Bioscience logo
$2.15 -0.05 (-2.27%)
(As of 10:30 AM ET)

Lexaria Bioscience (NASDAQ:LEXX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.61%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$5,008.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$10,268.00
Get LEXX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexaria Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LEXX Insider Buying and Selling by Quarter

Lexaria Bioscience Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/12/2024Catherine C TurkelDirectorBuy1,600$3.13$5,008.00  
7/31/2024Vanessa CarleinsiderSell2,567$4.00$10,268.00  
(Data available from 1/1/2013 forward)

LEXX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Lexaria Bioscience includes Catherine C Turkel, and Vanessa Carle. Learn more on insiders at LEXX.

7.61% of Lexaria Bioscience stock is owned by insiders. Learn more on LEXX's insider holdings.

The following insider purchased LEXX shares in the last 24 months: Catherine C Turkel ($9,268.00).

Insiders have purchased a total of 3,100 LEXX shares in the last 24 months for a total of $9,268.00 bought.

The following insider sold LEXX shares in the last 24 months: Vanessa Carle ($10,268.00).

Insiders have sold a total of 2,567 Lexaria Bioscience shares in the last 24 months for a total of $10,268.00 sold.

Lexaria Bioscience Key Executives

  • Mr. Christopher A. Bunka (Age 62)
    Chairman & CEO
    Compensation: $291.19k
  • Mr. John M. Docherty M.Sc. (Age 55)
    President & Director
    Compensation: $290.46k
  • Mr. Nelson D. Cabatuan CPA (Age 45)
    Chief Financial Officer
  • Kristin Hamilton
    Director of Operations
  • Vanessa Carle
    Head of Legal
    1 recent trades
  • Dr. Philip N. Ainslie Ph.D.
    Advisor & Consultant


This page (NASDAQ:LEXX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners